Intestinal Polyposis (Polyposis, Intestinal)

06/01/2003 - "Cronkhite-Canada syndrome: sustained remission after corticosteroid treatment."
09/01/2020 - "Cronkhite-Canada Syndrome Successfully Treated by Corticosteroids before Presenting Typical Ectodermal Symptoms."
05/26/2020 - "Objective: To clarify the endoscopic changes prior to corticosteroid therapy in Cronkhite-Canada syndrome (CCS) patients and to explore the correlation between endoscopic features and clinical characteristics. "
04/01/2007 - "Corticosteroid-responsive Cronkhite-Canada syndrome complicated by thrombosis."
01/01/2013 - "The treatment of Cronkhite-Canada syndrome includes symptomatic and support therapy, administration of corticosteroids, antibiotics and acid inhibitors, therapeutic endoscopy, and surgery. "

04/01/2024 - "Although prednisolone treatment is effective in Cronkhite-Canada syndrome (CCS), its mechanisms of action are poorly understood. "
08/01/1997 - "[A high CEA level in a case of Cronkhite-Canada syndrome, showing decrease by prednisolone treatment]."
04/01/2003 - "[A case of Cronkhite-Canada syndrome showing specific nail deformity after remission with prednisolone]."
04/01/2024 - "Analyses of cytokine gene expression and fecal microbiota in a patient with Cronkhite-Canada syndrome successfully treated with prednisolone."

01/01/2002 - "Cronkhite-Canada syndrome can be considered a zinc-deficiency disorder caused by gastrointestinal polyposis."
01/01/2002 - "A case of Cronkhite-Canada syndrome whose major complaint, taste disturbance, was improved by zinc therapy."
12/01/2006 - "We present a case of Cronkhite-Canada syndrome in a 58-year-old man who, after combined treatment with corticosteroids, disodium cromoglycate, loratadine, ciprofloxacin, and zinc, showed complete clinical and partial endoscopic remission. "

04/01/1992 - "Using fecal alpha-1-antitrypsin (FA-1-AT) as an endogenous marker of enteric protein loss, measurements on random non-dried stool samples were carried out in 20 normal healthy subjects and 30 patients with schistosomal hepatic fibrosis (SHF); 12 of them had intestinal polyposis (IP) and better hepatic functions than the others. "
04/01/2005 - "Based on our finding, Technetium-99m-labeled human serum albumin scintigraphy is helpful to localize the protein-losing origins and surgery is an effective treatment for Cronkhite-Canada syndrome with protein-losing enteropathy."
06/01/1998 - "[A case of Cronkhite-Canada syndrome with multiple adenomas and a carcinoma of rectum detected after improvement of polyposis due to steroid treatment--an analysis of expression of p53 protein in polyps]."

12/01/2006 - "We present a case of Cronkhite-Canada syndrome in a 58-year-old man who, after combined treatment with corticosteroids, disodium cromoglycate, loratadine, ciprofloxacin, and zinc, showed complete clinical and partial endoscopic remission. "

05/01/2020 - "Here, we describe a 59-year-old woman with Cronkhite-Canada syndrome in whom clinical manifestations were considerably relieved after treatment with prednisone."

12/01/2006 - "We present a case of Cronkhite-Canada syndrome in a 58-year-old man who, after combined treatment with corticosteroids, disodium cromoglycate, loratadine, ciprofloxacin, and zinc, showed complete clinical and partial endoscopic remission. "

12/01/2006 - "We present a case of Cronkhite-Canada syndrome in a 58-year-old man who, after combined treatment with corticosteroids, disodium cromoglycate, loratadine, ciprofloxacin, and zinc, showed complete clinical and partial endoscopic remission. "

04/01/2005 - "Application of technetium-99m-labeled human serum albumin scan to assist surgical treatment of protein-losing enteropathy in Cronkhite-Canada syndrome: report of a case."
04/01/2005 - "Based on our finding, Technetium-99m-labeled human serum albumin scintigraphy is helpful to localize the protein-losing origins and surgery is an effective treatment for Cronkhite-Canada syndrome with protein-losing enteropathy."

01/01/2014 - "We challenged APCMin/+ mice with gastrin, PPI, PPI and gastrin together for 10 weeks and counted intestinal polyposis accompanied with molecular changes. "
08/01/2013 - "Intraperitoneal gastrin significantly increased intestinal polyposis in APC(Min/⁺) mice (P<0.005), in which significant increases in macrophage were noted on F4/80 immunohistochemical staining (Plt;0.05) as well as Ki-67 staining (Plt;0.05) after gastrin. "
08/01/2013 - "In the current study, intestinal polyposis of APC(Min/⁺) mice was compared between phosphate buffered saline (PBS) injected and gastrin (10 μg/kg, thrice per week) injected group. "
01/01/2014 - "Gastrin significantly increased intestinal polyposis, but combination of PPI and gastrin markedly attenuated intestinal polyposis compared to gastrin-promoted APCMin/+ mice (P<.001), in which significant β-catenin phosphorylation and inhibition of β-catenin nuclear translocation were observed with PPI alone or combination of PPI and gastrin, whereas gastrin treatment significantly increased β-catenin nuclear translocation. "
08/01/2013 - "Conclusively, gastrin promoted intestinal polyposis through either direct gastrin receptor-mediated proliferative signaling or fostering tumor microenvironment such as macrophage activation."

01/01/2008 - "A case of Cronkhite-Canada syndrome: remission after treatment with anti-Helicobacter pylori regimen."
05/01/1999 - "[Endoscopic and pathological changes of gastric lesion before onset, during and after treatment in a patient with Cronkhite-Canada syndrome]."
05/01/2020 - "Here, we describe a 59-year-old woman with Cronkhite-Canada syndrome in whom clinical manifestations were considerably relieved after treatment with prednisone."

01/01/2018 - "Cronkhite-Canada Syndrome: Sustained Clinical Response with Anti-TNF Therapy."
01/01/2018 - "The etiology of Cronkhite-Canada syndrome is currently unknown, and the optimal therapy has not been reported so far. "
01/01/2013 - "We describe a severe case of Cronkhite-Canada syndrome and review the clinical features and therapy in 49 Chinese patients. "
01/01/2013 - "A severe course of Cronkhite-Canada syndrome and the review of clinical features and therapy in 49 Chinese patients."
02/01/2002 - "We report the case of a patient with Cronkhite-Canada syndrome (CCS) successfully treated with combination medical therapy. "

09/01/2003 - "[Iliac mucosa changes in late periods after total colectomy in patients with syndromes of gastro-intestinal polyposis]."
11/01/1981 - "A case of Cronkhite-Canada syndrome developing after hemi-colectomy."
03/01/2013 - "Subtotal colectomy for severe protein-losing enteropathy associated with Cronkhite-Canada syndrome: a case report."
01/01/2013 - "Spontaneous Regression of Polyposis following Abdominal Colectomy and Helicobacter pylori Eradication for Cronkhite-Canada Syndrome."
01/01/2001 - "Cronkhite-Canada syndrome associated with advanced rectal cancer treated by a subtotal colectomy: report of a case."

01/01/2002 - "Chemoprevention of intestinal polyposis by COX-2 inhibition: from mouse to man."
10/01/2006 - "Cancer chemoprevention of intestinal polyposis in ApcMin/+ mice by sulforaphane, a natural product derived from cruciferous vegetable."
02/15/2001 - "Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor."

06/01/1977 - "Subtotal gastrectomy was performed and at the subsequent pathologic-anatomic examination, the diagnosis of Cronkhite-Canada syndrome was made. "
06/01/2016 - "The second case was a 64-year-old man with malabsorption from Cronkhite-Canada Syndrome (CCS) and history of subtotal gastrectomy presenting with macrocytic anemia and neutropenia. "